Gary graduated from Bath University in 1987 with a BPharm (hons) in Pharmacy. He spent a year working as a hospital pharmacist before completing his PhD at the University of London on the stability of nonaqueous nonpolar suspensions. He joined the pharmaceutical industry immediately after his PhD, initially in formulation development roles, gaining experience across multiple types of medicine and drug substances, including small molecules, proteins and RNA-based therapeutics. He has held a number of Senior Director positions, including the global leadership of early-phase developability and product design departments focussing on acceleration to clinical studies. He has particular expertise in inhaled product development, and has worked across all phases of development from lead optimisation to initial commercial supply in support of the creation of GSK’s Ellipta portfolio of inhaled medicines.
Gary is now CatSci’s Director of Pharmaceutical Development, where he focuses on offering our customers tailored and value-adding solutions with an end-in-mind approach.